Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
CBL-514 by Caliway Biopharmaceutics for Cellulite: Likelihood of Approval
CBL-514 is under clinical development by Caliway Biopharmaceutics and currently in Phase II for Cellulite. According to GlobalData, Phase II...
Data Insights
CBL-514 by Caliway Biopharmaceutics for Adiposis Dolorosa (Dercum's Disease or Anders Disease): Likelihood of Approval
CBL-514 is under clinical development by Caliway Biopharmaceutics and currently in Phase II for Adiposis Dolorosa (Dercum's Disease or Anders...